LEVAMISOLE

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C11H12N2S
Molecular Weight	204.291
Optical Activity	UNSPECIFIED
Defined Stereocenters	1 / 1
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure of LEVAMISOLE

Structure Search

SMILES

C1CN2C[C@@H](N=C2S1)C3=CC=CC=C3

InChI

InChIKey=HLFSDGLLUJUHTE-SNVBAGLBSA-N

InChI=1S/C11H12N2S/c1-2-4-9(5-3-1)10-8-13-6-7-14-11(13)12-10/h1-5,10H,6-8H2/t10-/m1/s1

HIDE SMILES / InChI

Molecular Formula	C11H12N2S
Molecular Weight	204.291
Charge	0
Count

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	1 / 1
E/Z Centers	0
Optical Activity	UNSPECIFIED

Approval Year

Substance Class	Chemical Created by `admin` on `Fri Dec 15 15:05:30 UTC 2023` Edited by `admin` on `Fri Dec 15 15:05:30 UTC 2023`
Record UNII	2880D3468G
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

LEVAMISOLE

Official Name

English

(-)-2,3,5,6-TETRAHYDRO-6-PHENYLIMIDAZO(2,1-B)THIAZOLE

Systematic Name

English

LEVAMISOLE [VANDF]

Common Name

English

LEVAMISOLE [MI]

Common Name

English

Levamisole [WHO-DD]

Common Name

English

levamisole [INN]

Common Name

English

KETRAX

Brand Name

English

LEVAMISOLE [GREEN BOOK]

Common Name

English

IMIDAZO(2,1-B)THIAZOLE, 2,3,5,6-TETRAHYDRO-6-PHENYL-, (S)-

Systematic Name

English

LEVAMISOL

Common Name

English

TETRAMISOLE, (S)-

Common Name

English

LEVAMISOLE [MART.]

Common Name

English

Classification Tree Code System Code

WHO-ESSENTIAL MEDICINES LIST

6.1.1

Created by admin on Fri Dec 15 15:05:30 UTC 2023 , Edited by admin on Fri Dec 15 15:05:30 UTC 2023

CFR

21 CFR 520.1242D

Created by admin on Fri Dec 15 15:05:30 UTC 2023 , Edited by admin on Fri Dec 15 15:05:30 UTC 2023

NCI_THESAURUS

C2141

Created by admin on Fri Dec 15 15:05:30 UTC 2023 , Edited by admin on Fri Dec 15 15:05:30 UTC 2023

CFR

21 CFR 520.1242A

Created by admin on Fri Dec 15 15:05:30 UTC 2023 , Edited by admin on Fri Dec 15 15:05:30 UTC 2023

LIVERTOX

549

Created by admin on Fri Dec 15 15:05:30 UTC 2023 , Edited by admin on Fri Dec 15 15:05:30 UTC 2023

CFR

21 CFR 520.1242

Created by admin on Fri Dec 15 15:05:30 UTC 2023 , Edited by admin on Fri Dec 15 15:05:30 UTC 2023

WHO-VATC

QP52AE51

Created by admin on Fri Dec 15 15:05:30 UTC 2023 , Edited by admin on Fri Dec 15 15:05:30 UTC 2023

CFR

21 CFR 520.1242G

Created by admin on Fri Dec 15 15:05:30 UTC 2023 , Edited by admin on Fri Dec 15 15:05:30 UTC 2023

CFR

21 CFR 524.1240

Created by admin on Fri Dec 15 15:05:30 UTC 2023 , Edited by admin on Fri Dec 15 15:05:30 UTC 2023

WHO-ATC

P02CE01

Created by admin on Fri Dec 15 15:05:30 UTC 2023 , Edited by admin on Fri Dec 15 15:05:30 UTC 2023

WHO-VATC

QP52AE01

Created by admin on Fri Dec 15 15:05:30 UTC 2023 , Edited by admin on Fri Dec 15 15:05:30 UTC 2023

CFR

21 CFR 520.1242F

Created by admin on Fri Dec 15 15:05:30 UTC 2023 , Edited by admin on Fri Dec 15 15:05:30 UTC 2023

CFR

21 CFR 520.1242B

Created by admin on Fri Dec 15 15:05:30 UTC 2023 , Edited by admin on Fri Dec 15 15:05:30 UTC 2023

CFR

21 CFR 520.1242C

Created by admin on Fri Dec 15 15:05:30 UTC 2023 , Edited by admin on Fri Dec 15 15:05:30 UTC 2023

Code System Code Type Description

ECHA (EC/EINECS)

238-836-5

Created by admin on Fri Dec 15 15:05:30 UTC 2023 , Edited by admin on Fri Dec 15 15:05:30 UTC 2023

PRIMARY

DRUG CENTRAL

1561

Created by admin on Fri Dec 15 15:05:30 UTC 2023 , Edited by admin on Fri Dec 15 15:05:30 UTC 2023

PRIMARY

PUBCHEM

26879

Created by admin on Fri Dec 15 15:05:30 UTC 2023 , Edited by admin on Fri Dec 15 15:05:30 UTC 2023

PRIMARY

DRUG BANK

DB00848

Created by admin on Fri Dec 15 15:05:30 UTC 2023 , Edited by admin on Fri Dec 15 15:05:30 UTC 2023

PRIMARY

CAS

14769-73-4

Created by admin on Fri Dec 15 15:05:30 UTC 2023 , Edited by admin on Fri Dec 15 15:05:30 UTC 2023

PRIMARY

DAILYMED

2880D3468G

Created by admin on Fri Dec 15 15:05:30 UTC 2023 , Edited by admin on Fri Dec 15 15:05:30 UTC 2023

PRIMARY

CHEBI

6432

Created by admin on Fri Dec 15 15:05:30 UTC 2023 , Edited by admin on Fri Dec 15 15:05:30 UTC 2023

PRIMARY

LACTMED

Levamisole

Created by admin on Fri Dec 15 15:05:30 UTC 2023 , Edited by admin on Fri Dec 15 15:05:30 UTC 2023

PRIMARY

FDA UNII

2880D3468G

Created by admin on Fri Dec 15 15:05:30 UTC 2023 , Edited by admin on Fri Dec 15 15:05:30 UTC 2023

PRIMARY

ChEMBL

CHEMBL1454

Created by admin on Fri Dec 15 15:05:30 UTC 2023 , Edited by admin on Fri Dec 15 15:05:30 UTC 2023

PRIMARY

IUPHAR

7210

Created by admin on Fri Dec 15 15:05:30 UTC 2023 , Edited by admin on Fri Dec 15 15:05:30 UTC 2023

PRIMARY

MERCK INDEX

m6781

Created by admin on Fri Dec 15 15:05:30 UTC 2023 , Edited by admin on Fri Dec 15 15:05:30 UTC 2023

PRIMARY

Merck Index

SMS_ID

100000082821

Created by admin on Fri Dec 15 15:05:30 UTC 2023 , Edited by admin on Fri Dec 15 15:05:30 UTC 2023

PRIMARY

WIKIPEDIA

LEVAMISOLE

Created by admin on Fri Dec 15 15:05:30 UTC 2023 , Edited by admin on Fri Dec 15 15:05:30 UTC 2023

PRIMARY

EPA CompTox

DTXSID4023206

Created by admin on Fri Dec 15 15:05:30 UTC 2023 , Edited by admin on Fri Dec 15 15:05:30 UTC 2023

PRIMARY

EVMPD

SUB08454MIG

Created by admin on Fri Dec 15 15:05:30 UTC 2023 , Edited by admin on Fri Dec 15 15:05:30 UTC 2023

PRIMARY

NCI_THESAURUS

C61609

Created by admin on Fri Dec 15 15:05:30 UTC 2023 , Edited by admin on Fri Dec 15 15:05:30 UTC 2023

PRIMARY

INN

2643

Created by admin on Fri Dec 15 15:05:30 UTC 2023 , Edited by admin on Fri Dec 15 15:05:30 UTC 2023

PRIMARY

RXCUI

6371

Created by admin on Fri Dec 15 15:05:30 UTC 2023 , Edited by admin on Fri Dec 15 15:05:30 UTC 2023

PRIMARY

RxNorm

MESH

D007978

Created by admin on Fri Dec 15 15:05:30 UTC 2023 , Edited by admin on Fri Dec 15 15:05:30 UTC 2023

PRIMARY

Related Record Type Details


					DL9055K809

LEVAMISOLE HYDROCHLORIDE

SALT/SOLVATE -> PARENT


					FIG89N8AZY

LEVAMISOLE PHOSPHATE

SALT/SOLVATE -> PARENT


					C8M7RFE4NO

RACEMATE -> ENANTIOMER

Related Record Type Details


					AC57BIX3H8

2-OXO-3-(2-MERCAPTOETHYL)-5-PHENYLIMIDAZOLIDINE, (±)-

METABOLITE ACTIVE -> PRODRUG

Interaction Type:

MAJOR


					F0IVI400Q4

4-HYDROXY-LEVAMISOLE

METABOLITE -> PARENT

Qualification:

URINE

Amount:


					AC57BIX3H8

2-OXO-3-(2-MERCAPTOETHYL)-5-PHENYLIMIDAZOLIDINE, (±)-

METABOLITE ACTIVE -> PRODRUG

Related Record Type Details


					KEA4JRD166

6-PHENYL-2,3-DIHYDROIMIDAZO(2,1-B)THIAZOLE

IMPURITY -> PARENT

Comments:

- for veterinary use - correction factor: for the calculation of content, multiply the peak area of impurity D by 1.3

Interaction Type:

CHROMATOGRAPHIC PURITY (HPLC/UV)

Qualification:

EP

Amount:


					60AQZ8W67M

2-THIAZOLIDINIMINE, 3-(2-PHENYLETHENYL)-, (E)-

IMPURITY -> PARENT

Comments:

- for veterinary use - correction factor: for the calculation of content, multiply the peak area of impurity B by 1.7

Interaction Type:

CHROMATOGRAPHIC PURITY (HPLC/UV)

Qualification:

EP

Amount:


					173GB6WA7L

BIS(2-(2-OXO-4-PHENYLIMIDAZOLIDIN-1-YL)ETHYL) DISULFIDE

IMPURITY -> PARENT

Comments:

- for veterinary use - correction factor: for the calculation of content, multiply the peak area of impurity E by 2.7

Interaction Type:

CHROMATOGRAPHIC PURITY (HPLC/UV)

Qualification:

EP

Amount:


					DR0A93EA6K

3-(.BETA.-AMINOPHENETHYL)-2-THIAZOLIDINONE

IMPURITY -> PARENT

Comments:

- for veterinary use - correction factor: for the calculation of content, multiply the peak area of impurity A by 2.0

Interaction Type:

CHROMATOGRAPHIC PURITY (HPLC/UV)

Qualification:

EP

Amount:


					AC57BIX3H8

2-OXO-3-(2-MERCAPTOETHYL)-5-PHENYLIMIDAZOLIDINE, (±)-

IMPURITY -> PARENT

Comments:

- for veterinary use - correction factor: for the calculation of content, multiply the peak area of impurity C by 2.9

Interaction Type:

CHROMATOGRAPHIC PURITY (HPLC/UV)

Qualification:

EP

Amount: